Mammals are able to convert inorganic arsenic to mono-, di-, and trimethylated metabolites. In previous studies we have shown that the trivalent organoarsenic compounds are more toxic than their inorganic counterparts and that the toxicity is associated with the cellular uptake of the arsenicals. In the present study, we investigated cyto-/genotoxic effects of the arsenic compounds arsenate [As i (V) (24 h) and compared the uptake capabilities of fibroblasts (CHO-9 cells: Chinese hamster ovary) used for genotoxicity studies, with those of hepatic cells (Hep G2: hepatoma cell-line). To find out whether the arsenic compounds are bound to membranes or if they are present in the cytosol, the amount of arsenic was measured in whole-cell extracts and in membraneremoved cell extracts by inductively coupled plasma-mass spectrometry (ICP-MS). In addition, we forced the cellular uptake of the arsenic compounds into CHO-9 cells by electroporation and measured the intracellular arsenic concentrations before and after this procedure. Our results show that organic and inorganic arsenicals are taken up to a higher degree by fibroblasts compared to hepatoma cells. The arsenic metabolite DMA(III) was the most membrane permeable species in both cell lines and induced strong genotoxic effects in CHO-9 cells after an exposure time of 24 h. The uptake of all other arsenic species was relatively low (<1% by Hep G2 and <4% by CHO cells), but was dose-dependent. Electroporation increased the intracellular arsenic levels as well as the number of induced MN in CHO-9 cells. With the exception of As i (III) and DMA(III) in CHO-9 cells, the tested arsenic compounds were not bound to cell membranes, but were present in the cytosol. This may indicate the existence of DMA(III)-specific exporter proteins as are known for As i (III). Our results indicate that the uptake capabilities of arsenic compounds are highly dependent upon the cell type. It may be hypothesized that the arsenic-induced genotoxic effects observed in fibroblasts are due to the high uptake of arsenicals into this cell type. This may explain the high susceptibility of skin fibroblasts to arsenic exposure.
Arsenic enters the biosphere primarily by leaching from geological formations and thus can pollute ground and surface water. The contamination of drinking water by arsenic is a public health hazard that affects millions of people, in particular in Asia and South America. The acute as well as chronic exposure of humans to arsenic in drinking water has been reported in numerous studies (Goering et al., 1999; Gradecka et al., 2001; Tchounwou et al., 1999) . The outcome of this exposure can be devastating, often leading to various forms of malignancies such as skin cancer (Rossman et al., 2004; Smith et al., 1992) . The ubiquity of arsenic in the environment has led to the evolution of arsenic defense mechanisms in almost every organism studied from Escherichia coli to man (Bhattacharjee et al., 1999) .
Microorganisms take up As i (V) in the form of arsenate via phosphate transporters Rosen, 2002; Yompakdee et al., 1996) and it can be assumed that arsenate is taken up similarly in mammals, although this has not been demonstrated. In contrast, glycerol channels appear to play a key role in the cellular uptake of As i (III), e.g., the glycerol channel Fps1p has been shown to mediate the uptake of both As i (III) and Sb i (III) in the yeast Saccharomyces cerevisiae, and the mammalian aquaglyceroporins AQP7 and AQP9 have been reported to catalyse uptake of As i (III) and Sb i (III) . As i (V) is reduced to As i (III) by arsenate reductases (Ji and Silver, 1992; Oden et al., 1994) . As i (III) is extruded from cells or sequestered in intracellular compartments, either as free arsenite or as a conjugate with GSH or other thiols (Ghosh et al., 1999; Kala et al., 2000) . In addition, arsenic can be methylated (Aposhian, 1997) , although this process may increase arsenic toxicity rather than contributing toward detoxification since certain metabolic intermediates are more toxic than the inorganic arsenic (Styblo et al., 2000) . Dopp et al. (2004) have demonstrated that only a relatively small percentage (about 1-2%) of the initial As i loading is taken up by CHO-9 cells and can be detected in cell free extract. The highest arsenic uptake was detectable at relatively low concentrations (500 nM As i (III): 1.2%, 1 lM As i (V): 1.6%) and the relative uptake decreased with increasing arsenic concentrations in the external medium. The authors concluded that a defense mechanism exists involving arsenic extrusion and that uptake at higher arsenic concentrations is inhibited. Trivalent methylarsenic species were more membrane-permeable than the pentavalent forms; up to 10% of the initial trivalent methylarsenic acid dose was taken up. The order of cellular uptake for the arsenic compounds in the trivalent state was DMA(III)>MMA(III)>As i (III), and for pentavalent arsenic compounds As i (V)>MMA(V)>DMA(V)>TMAO (Dopp et al., 2004) . The higher uptake of the trivalent methylated arsenicals may be responsible for the reported greater genotoxic effects of these compounds (e.g., Mass et al., 2001; Schwerdtle et al., 2003; Yamanaka et al., 2004) .
In the present study, we compare the uptake capabilities of fibroblasts (CHO-9 cells) used for genotoxicity studies with those of hepatoma cells (Hep G2). These cells were chosen because the liver is the primary site of arsenic metabolism within the body and skin, along with the bladder, is a target organ for arsenic carcinogenicity. The cellular uptake of the arsenic compounds was forced by electroporation to test the hypothesis that arsenic-induced genotoxic effects are related to the intracellular arsenic concentration and dependent upon uptake. Also, we investigated whether the arsenic compounds are bound to membranes or whether they are present in the cytosol. For these investigations we removed the cell membranes by osmotic lysis and subsequent centrifugation before the intracellular arsenic concentrations were measured by ICP-MS.
MATERIALS AND METHODS
Cell cultures. CHO-9 cells (obtained from A. T. Natarajan, Leiden, The Netherlands) were grown in 25 cm 2 culture flasks (Greiner) with McCoys 5A medium (Gibco) supplemented with 10% fetal calf serum (Gibco) in the presence of 100 IU/ml penicillin and 100 lg/ml streptomycin (Gibco) at 37°C and 5% CO 2 .
Hep G2 cells (ATCC, HB 8065) were maintained at 37°C and 5% CO 2 in Minimum Essential Medium (MEM) with Earle's BSS and sodium-bicarbonate (CC PRO, Germany) supplemented with 10% heat-inactivated FCS (Gibco), non-essential amino acids (0.1 mM), sodium-pyruvate (1 mM), and 100 IU/ml penicillin/streptomycin (CC PRO, Germany).
Reagents. Sodium arsenite (AsNaO 2 ) and sodium arsenate (AsHNa 2 O 4 Á7H 2 0) were purchased from Fluka (Seelze, Germany) and Sigma (Taufkirchen, Germany), respectively. Dimethylarsinic acid (Me 2 AsOOH) was obtained from Strem (Kehl, Germany), and monomethylarsonic acid (MeAsO(OH) 2 ) as well as trimethylarsine oxide (Me 3 AsO) were from TriChemical Laboratories Inc. (Yamanashi, Japan). Monomethyldiiodoarsine (MeAsI 2 ) and dimethyliodoarsine (Me 2 AsI) were purchased from Argus Chemicals (Vernio, Italy). Preparation of dilute solutions of these iodide precursors results in the formation of the corresponding acids, monomethylarsonous acid (MeAs(OH) 2 ) and dimethylarsinous acid (Me 2 AsOH) (Gong et al., 2001; Millar et al., 1960) . All chemicals were of analytical grade or of the highest quality obtainable. Solutions of arsenicals were prepared in sterile McCoys 5A, Ham's F12K, or MEM medium, respectively, and stored at ÿ20°C until used. The stability of the arsenicals in the culture medium was tested by HPLC-hydride generation-atomic fluorescence spectrometry (HPLC-HG-AFS) using the method of Le et al. (2000) . Due to the high volatility and sensitivity to oxidation of dimethylarsinous acid, solutions of this arsenical were always prepared immediately before each experiment and were discarded if not used within a two-day period. All other arsenicals tested, including the trivalent compounds sodium arsenite and monomethylarsonous acid, were found to be stable over a minimum two month period. All arsenicals used in the cytotoxicity, genotoxicity, uptake, and electroporation experiments are listed in Table 1 .
Trypan blue, Cytochalasin B, May-Grünwald and Giemsa solutions were purchased from Sigma, and the hypoosmotic buffer for electroporation from Eppendorf (Germany).
Cytotoxicity test. CHO-9 and Hep G2 cells were treated with the arsenicals at different concentrations for 24 h, and all experiments were performed in duplicate. Cell viability was evaluated immediately after exposure. Treated and untreated cells were harvested by trypsin treatment (Sigma). Cell counting was performed following trypan blue staining. The cell suspension was mixed with an equivalent volume of 0.4% trypan blue solution (Sigma) and subsequently evaluated under the light microscope. Cell viability is expressed as percentage of surviving cells compared to the total number of cells. Significance was tested by using the Student's t-test.
Cytokinesis blocked micronucleus assay (CBMN) and Nuclear division index (NDI). For MN analysis, 2 3 10 5 CHO-9 cells were seeded in each well of Quadriperm-dishes (Viva-Science, Sartorius, Göttingen, Germany) and cultured overnight. Then the arsenic compounds were applied for 24 h at different concentrations (0.1 lM to 7.5 mM). Subsequently, the cells were washed twice with PBS and incubated for an additional period of 24 h with cytochalasin B (3 lg/ml) to block cytokinesis (recovery time). Cells were fixed by treating with Carnoy's solution (methanol:acetic acid, 3:1) for 5 min and stained with May-Grünwald and 6% Giemsa solution. The frequency of MN formation was expressed as percentage of binucleated (bn) cells with MN. 2000 bn cells were evaluated in each case, and all experiments were performed at least in duplicate.
Using the cytokinesis-blocked MN assay, the extent and progression of nuclear division could be assessed by analysing the NDI. After exposure of cells to non-cytotoxic concentrations of the arsenic compounds for 24 h, cells were incubated with cytochalasin B (3 lg/ml) for additional periods of 14 h, 28 h, or 35 h, respectively. The frequency of mononucleated (MI), binucleated (MII), and multinucleated (MIII þ MIV) cells after cytochalasin-B treatment was determined. A minimum of 1000 cells/slide was analyzed.
Electroporation. Electroporation according to Eppendorf Soft Pulse technology was carried out in hypoosmolar buffer (250 mOsmol/kg), in which the cells absorb water shortly before the pulse and then swell up as a result of the treatment. A number of effects, including a decreased optimal pulse voltage, ensure that the plasma membrane can be permeated more easily. The tolerance of CHO-9 cells to hypoosmolar conditions was tested in preliminary experiments. The survival rate of the cells was >90%.
Electroporation and micronucleus assay. A suspension of cells (0.5 3 10 6 ) was prepared in medium for electroporation (basal medium þ 0.5 % FCS) and centrifuged. The tested arsenic species were dissolved in hypoosmotic buffer (concentration: 500 lM) and added to the cells to obtain a final volume of 800 ll. The cells were transferred to electroporation cuvettes with a 4 mm gap. The hypoosmotic exposure lasted 30 min, and electroporation was performed at 530 V for 40 ls. The cell suspension was allowed to stand for a maximum of 10 min at room temperature and was then centrifuged (190 3 g, 5 min). The cell pellet was washed twice in fresh culture medium and resuspended in 5 ml fresh medium containing cytochalasin B (3 lg/ml). Following an incubation period of 24 h (recovery time), the CBMN-assay was carried out. The experiments were set up as follows: (a) unexposed control, (b) unexposed control and electroporation, (c) exposed with arsenicals, and (d) exposed with arsenicals and electroporation. All experiments were performed in triplicate.
Cellular uptake of arsenic. To assess the membrane permeability of the arsenic compounds under normal and forced conditions, CHO-9 cells were incubated with the arsenic compounds at different concentrations (0.1 lM-10 mM) for an exposure time of 1 h and 24 h. Since the results obtained from experiments with exposure periods of 1 h and 24 h did not differ significantly, all uptake experiments were performed over a period of 1 h. For comparison of arsenic uptake in different cell lines, 8.8 3 10 6 CHO or 3.3 3 10 6 Hep G2 cells were exposed to the different arsenic species. Following incubation, cells were washed with PBS and subsequently resuspended in 10 ml fresh culture medium. After cell counting, the cell suspension was centrifuged for 5 min at 190 3 g and the pellet was resuspended in 10 ml distilled water to lyse the cells (for at least 30 min). The absence of intact cells was confirmed by microscopic examination. From this cell solution two kinds of samples were prepared: (a) whole-cell extract with membranes and proteins present, and (b) cell-free (membrane removed) extract, obtained by osmotic lysis of the whole-cell extract with subsequent centrifugation (1700 3 g, 15 min) to remove the membranes. The samples were stored at ÿ20°C until ICP-MS analysis.
For electroporation approximately 1 3 10 6 CHO-9 cells were prepared in basal medium þ 0.5% FCS and centrifuged. Solutions of each arsenic species (5, 50, 500 lM) were prepared in hypoosmotic buffer and added to the cells to achieve a final volume of 800 ll. The cells were transferred to electroporation cuvettes with a 4 mm gap. Samples were treated with electrical impulses of 530 V for 40 ls and all experiments were performed in triplicate. The cell suspension was allowed to stand for 10 min at room temperature and then centrifuged (5 min, 190 3 g) and washed twice in fresh culture medium. Whole-cell and cell-free extract samples were prepared as described above.
Analysis of intracellular arsenic concentration. Total arsenic concentrations in the cell extracts were determined by inductively coupled plasmamass spectrometry (ICP-MS) (Agilent 7500a, Agilent Technologies, Germany). The ICP-MS was operated at 1260 W rf-power, with argon flows of 15 l min ÿ1 (plasma gas), 0.98 l min ÿ1 (carrier gas), and 0.9 l min ÿ1 (auxiliary gas).
Solutions (up to 1 in 100 dilutions) were delivered at 0.3 ml/min to a Babington nebulizer and routed through a double-pass Scott-type spray chamber maintained at 2°C. In (1000 ms) were monitored. Apart from the signal obtained at m/z 75 for the analyte arsenic and from that at m/z 115 for the internal standard indium, the signal at m/z 77 was monitored in order to control chloride interference. Quantitation was performed by external calibration with an arsenate standard solution and validated by analyzing CRM SERO B2.
Statistics. The chi-square-test was used for the statistical analysis of the results of the micronucleus assay and the two-tailed Student's t-test for evaluating the data from the cytotoxicity test and the NDI.
RESULTS

Cellular Uptake
Up to 2% of the As i (V) substrate in the external medium was taken up by CHO-9 cells, and up to 4% of As i (III). This highest percentage of arsenate/arsenite uptake in CHO cells was detected at an external concentration of 1 lM. A concentration-dependency was observed in this cell line, which reached a maximum at 500 lM As i (III) and at 1 mM As i (V) ( Table 2 ). The pentavalent species MMA(V), DMA(V), and TMAO (V) were taken up to a significantly lower degree than the inorganic and the trivalent species. A concentration-dependency was observed for these species with a maximum uptake at the highest external concentration applied. DMA(III) was the most membrane-permeable arsenic species. Up to 16% of the initially applied arsenic in the culture medium (external concentration: 0.5 lM) was detected in the whole-cell extract and 9% could be measured intracellularly in the membrane-removed cell extract. These data indicate that around 7% of DMA(III) was bound to the cell membrane. With the exception of DMA(III) (0.5 lM, 1 lM) and As i (III) (1 lM), no significant difference in the uptake of arsenic species was observed between whole-cell extract and cell-free extract for CHO-9 cells (Table 2) .
The uptake of the organoarsenic compounds by Hep G2 cells was tested using concentrations from 0.5 lM to 5 mM for 1 h. As with CHO-9 cells, a concentration-dependency was observed for all compounds and DMA(III) was best taken up by the cells (Table 3) . The difference between the arsenic concentration in whole-cell extract and the cell-free extract was not significant in all cases. As i (III) and DMA(III) did not appear to associate with the cell membrane of Hep G2 cells as it did with CHO-9 cell membranes.
The intracellular concentration of arsenic was in most cases lower for Hep G2 cells than in CHO-9 cells. This difference was particularly marked for the trivalent DMA (III) species for which an up to 20-fold difference in intracellular arsenic concentration between CHO-9 and Hep G2 cells was observed (0.5 lM substrate loading) (Tables 2 and 3 ). Intracellular arsenic concentrations for As i (III), As i (V), MMA(III), and TMAO were 2-4-fold higher in CHO-9 than in Hep G2 cells. In contrast, no significant difference in intracellular MMA(V) or DMA(V) was noted between CHO-9 and Hep G2 cells (Tables 2 and 3 ).
The cellular uptake of the arsenic species by CHO-9 cells increased after treatment of cells using electroporation. The increased cellular uptake under electroporative conditions was significant for As i (III) ( p < 0.001), Asi(V) ( p < 0.001), MMA(III) ( p < 0.01), MMA(V) ( p < 0.05), and DMA(V) ( p < 0.05) (Fig. 1) .
Cytotoxicity Test
The trivalent arsenic compounds exerted higher cytotoxic effects in CHO-9 cells in comparison to the pentavalent arsenic Note. The amount of arsenic (ng/10 6 cells) as well as the percentage of substrate loading (%) was measured in whole cell extracts and in membrane-removed cell extracts by inductively coupled plasma-mass spectrometry (ICP-MS). Cells were exposed to arsenicals for 1 h. 8.8 3 10 6 cells were analyzed per treatment. Presented values represent means of duplicate incubations and five replicate analyses (mean %RSD ¼ 3.3%). ND, not detected (<0.02 ng As per 10 6 cells).
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DOPP ET AL. (Fig. 2) . After an exposure period of 24 h, both inorganic forms of arsenic were found to be cytotoxic (As i (III) at 100 lM, As i (V) at 500 lM) in CHO-9 cells. DMA(III) was cytotoxic at 10 lM and MMA(III) at 100 lM (24 h exposure) (Fig. 2) . A similar cytotoxicity profile was observed in Hep G2 cells: the trivalent organoarsenicals were most cytotoxic followed by the inorganic arsenic compounds and then the pentavalent organoarsenic species [DMA(III), MMA(III))As i (III), As i (V))MMA(V), DMA(V), TMAO(V)] (Fig. 3) . MMA(III) was more reactive in Hep G2 than in CHO-9 cells. The decrease in cell viability of MMA(III)-treated cells was significant at 100 lM in CHO-9 cells and at 10 lM in Hep G2 cells ( p < 0.01).
Micronucleus Assay and NDI
Exposure of CHO-9 cells to As i (V) for 24 h induced elevated numbers of MN at concentrations of 1, 5, 10, 25, and 50 lM, respectively (Fig. 4) . The number of micronucleated cells was not significantly increased when cells were exposed to MMA(V) for 24 h (Fig. 5) . In comparison to MMA(V), MMA(III) induced a significant increase in MN-formation at 5 lM ( p < 0.05) and 7.5 lM ( p < 0.001) during 24 h incubation. At higher concentrations of MMA(III) (> 20 lM) the MN-assay was not applicable anymore because of increased cytotoxic effects (Fig. 5) . Incubation of CHO cells with DMA(V) for 24 h did not induce elevated numbers of MN up to a tested concentration of 5 mM (data shown for concentrations up to 1 mM in Fig. 6 ). The formation of MN rose significantly at a tested concentration of 7.5 mM DMA(V) ( p < 0.05, exposure time: 24 h) (control: 18 ± 2.8 MN/1000 bn cells, 2.5 mM DMA(V): 20 ± 1.4 MN/1000 bn cells, 5 mM: 21 ± 0.7 MN/1000 bn cells, 7.5 mM: 33 ± 1.4 MN/1000 bn cells). DMA(III) was the most reactive arsenic species, inducing a maximum of 229 MN/1000 bn cells at 10 lM (24 h exposure) (Fig. 6) . Incubation with TMAO for 24 h did not significantly increase the number of MN (Fig. 7) .
The calculation of the NDI revealed that there was no significant cell cycle delay detectable after exposing CHO-9 cells for 24 h to 5 lM As i (III), 10 lM As i (V), 1 lM MMA(III), 1 mM MMA(V), 1 mM DMA(V), or 1 mM TMAO. Only incubation of cells with 0.5 lM DMA(III) significantly modified the NDI. After a recovery period of 14 h, a significant delay ( p < 0.05) of the cell cycle was found (2.45 ± 0.19 versus control with 1.77 ± 0.01). Using longer recovery periods (28 h and 35 h), this delay was not statistically significant anymore (data not shown).
Micronucleus Induction after Electroporation
The induction of micronucleated cells (MN) by the pentavalent organoarsenic species MMA(V), DMA(V), and TMAO was assessed in CHO-9 cells after electroporation. These compounds were chosen for electroporation experiments because they were negative in the MN assay under normal exposure conditions (Figs. 5-7) . No significant differences in MN induction were observed between the unexposed control and the unexposed control after electroporation. Exposure of FIG. 1. Uptake of arsenic compounds by CHO-9 cells under forced uptake (electroporation) condition. The cells were exposed to As i (III) 50 lM, As i (V) 500 lM, MMA(III) 50 lM, MMA(V) 500 lM, DMA(III) 5 lM, DMA(V) 500 lM, and TMAO(V) 500 lM for 30 min. Ko ¼ negative control, Ke ¼ electroporation control, E ¼ exposure to arsenic substrate (positive control), Ee ¼ exposure to arsenic substrate under electroporative conditions. All experiments were performed in triplicate.
CYTO-/GENOTOXIC EFFECTS OF ARSENIC COMPOUNDS 51 CHO-9 cells to 500 lM MMA(V), DMA(V), and TMAO for 30 min did not induce a significant increase of MN formation. After forced uptake of the arsenic compounds via electroporation, the number of induced MN was significantly increased ( p < 0.05, Fig. 8 ).
DISCUSSION
The approach to investigate human hepatoma cells as well as fibroblasts in one study is appropriate, since both liver and skin are target organs for the carcinogenicity of arsenic, and the liver is the main site of arsenic metabolism (Drobná et al., 2004) . The trivalent methylated arsenic derivative DMA(III) was the most membrane-permeable species (~16% uptake by CHO-9 cells from the external medium) and induced the highest genomic damage expressed as formed micronuclei. The uptake capabilities of DMA(III) by Hep G2 cells were much lower (~4.5% from the external medium at 10-fold higher concentrations) compared to CHO-9 fibroblasts. DMA(III) is neutrally charged at physiological pH, therefore it is able to diffuse into cells (most probably a facilitated   FIG. 2 . Cytotoxicity of pentavalent and trivalent arsenic compounds in CHO-9 cells. Cells were treated with various concentrations of As i (V) (n) and As i (III) (:), MMA(V) (h) and MMA(III) (n), DMA(V) (open diamond), and DMA(III) (shaded diamond) and TMAO(V) (þ) for 24 h. The percentage of decreased cell viability is shown in relation to the untreated control. The cytotoxicity was determined by trypan blue-staining. All experiments were performed in triplicate. SD 10%.
FIG. 3.
Cytotoxicity of pentavalent and trivalent arsenic compounds in Hep G2 cells. Cells were treated with various concentrations of As i (V) (n) and As i (III) (:), MMA(V) (h) and MMA(III) (n), DMA(V) (open diamond), and DMA(III) (shaded diamond) and TMAO(V) (þ) for 24 h. The percentage of decreased cell viability is shown in relation to the untreated control. The cytotoxicity was determined by trypan blue-staining. All experiments were performed in duplicate. SD 11%. diffusion mechanism as is known for the neutrally charged As i (III) (pKa 1 9.23, pKa 2 12.13, pKa 3 13.4) (Rosen, 2002) . The apparent lower intracellular DMA(III) concentration noted for Hep G2 cells may therefore best be explained by the presence of an enhanced efflux mechanism either for DMA(III) or a subsequent metabolite thereof.
The pentavalent methylated arsenic species are negatively charged at physiological pH (MMA (V) pKa 1 2.6, pKa 2 8.2, DMA(V) pKa 6.3, TMAO pKa 3.6) and were poorly taken up by both cell lines (0% to a maximum of 2%). No significant genomic damage was observed for MMA(V), DMA(V), or TMAO(V). After forced uptake of these species by electroporation the number of MN increased significantly in CHO-9 cells; intracellular concentrations of MMA(V), DMA(V), and TMAO(V) were also higher following electroporation. These data demonstrate that higher internal amounts of pentavalent organoarsenic species within the cell cause a higher degree of DNA damage and indicate that resistance to MMA(V), DMA(V), and TMAO(V) is controlled at the uptake level.
The reduction of the pentavalent arsenic species to the trivalent analogue, as described by the Challenger mechanism (Challenger, 1945) , is a metabolic process catalysed by MMA(V) reductase/human glutathione-S-transferase-omega (hGSTO-1) (Aposhian et al., 2004) , hence the possibility of the observed genotoxic effects being caused by the trivalent metabolites rather than by the pentavalent substrate itself must be considered. Preliminary data from HPLC-ICP-MS analysis of the membrane-removed cell-free extracts from MMA(V), DMA(V), and TMAO(V) incubations did not reveal the presence of trivalent arsenic species (data not shown); it remains to be established, however, as to whether this remains the case over a 24 h incubation period.
We have shown that most of the arsenic species (except DMA(III) and As i (III) in CHO-9 cells) are not bound to cellular membranes, but are able to enter the cytosol (no significant difference in arsenic concentration in whole-cell extract and membrane-removed cell extract). The differences between DMA(III) as well as As i (III) concentrations in whole-cell extract and in membrane-removed cell extract may be CYTO-/GENOTOXIC EFFECTS OF ARSENIC COMPOUNDS 53 explained by the presence of a specific exporter for these species. Active efflux of As i (III) has been reported in bacteria, yeast, and mammalian cells (Kimura et al., 2005; Rosen, 2002) , and Shiobara et al. (2001) have discussed the possibility of DMA(III) efflux from the liver. Furthermore, the detection of DMA(III) in urine has also been reported Mandal et al., 2001 ). The apparent lack of As i (III) export in Hep G2 cells may be explained by considering the high arsenic biotransformation capacity of hepatocytes. Efficient biotransformation of inorganic arsenic to methylarsenic species would remove the need for the extrusion of As i (III) as a significant resistance mechanism.
As i (III), As i (V), MMA(III), and DMA(III) were shown to induce genomic damage in CHO-9 cells after an incubation period of 24 h. In contrast, the pentavalent organoarsenic species MMA(V), DMA(V), and TMAO(V) did not induce genotoxic effects up to a concentration of 7 mM. DMA(III) was most reactive of all arsenicals tested in inducing micronuclei (>10-fold increase compared to control). Two mechanisms could be responsible for the observed genotoxic effects of the trivalent arsenicals: (1) induction of oxidative damage causing single-and/or double-strand breaks (Hei et al., 1998) and (2) modification of cellular functions by changing the phosphorylation profiles of cellular proteins (Huang et al., 1995) and inhibition of DNA repair enzymes Lynn et al., 1997; Yager and Wiencke, 1997) .
The dimethylated trivalent arsenic forms were more effective in expressing DNA damage than the monomethylated trivalent forms, possibly due to the involvement of such reactive oxygen species (ROS) as dimethylarsenic peroxyradicals [(CH 3 ) 2 AsOOd] ( Kenyon and Hughes, 2001; Noda et al., 2002; Yamanaka et al., 2001) . DMA(III) has been shown to form ROS which cause DNA damage in vivo (Bernstam and Nriagu, 2000; Liu et al., 2001; Lynn et al., 1998; Mandal et al., 2001; Wu et al., 2001) . Kessel et al. (2002) showed that arsenite is a potent chromosomal mutagen and that oxyradicals are involved in the mutagenic process. As a result of ROS production by arsenic DNA strand breaks (Okayasu et al., 2003) , oxidative DNA damage (Bau et al., 2002; Hartwig et al., 1997; Schwerdtle et al., 2003) and the formation of micronuclei can occur (Basu et al., 2004; Bernstam and Nriagu, 2000; Kato et al., 2003) . Arsenic can either enhance or reduce nitric oxide (NO) production, depending on the type of cell, the arsenic species, and the concentration of the tested arsenical. Suppression of NO production has been shown to reduce arseniteinduced oxidative DNA damage and micronucleus formation (Gurr et al., , 2003 ). An elevated resistance to As-induced genotoxicity in Hep G2 cells was reported by Gebel et al. (2002) . The authors did not find elevated numbers of induced micronuclei in Hep G2 cells after arsenic exposure.
A cell-cycle delay in arsenite-treated human leukaemia cells was reported by McCabe et al. (2000) . Kligerman et al. (2003) also observed a retardation of the cell-cycle after treatment of human lymphocytes with As i (III) and (V), MMA(III) and (V), and DMA(III) and (V) for 24 h. In our study, a recovery period was instituted, i.e., CHO-9 cells were treated with the different arsenicals for 24 h and after the treatment period, cells were incubated for additional 14 h to 35 h with cytochalasin B (recovery period). Hence, in contrast to the results of McCabe et al. (2000) and Kligerman et al. (2003) we detected no significant cell-cycle delay after exposing CHO-9 cells to As i (III) and (V), MMA(III) and (V), DMA(V), and TMAO. The NDI was significantly modified only after incubation of cells with DMA(III) and a short recovery period of 14 h. Taken together, these data indicate that arsenic compounds are able to temporarily delay the cell cycle, but that this delay is reversible. These results are in agreement with data of previous studies published by Dopp et al. (2004) where CHO-9 cells were exposed to organoarsenicals for periods of 1 h. After an extended exposure time of 24 h (and a recovery period of 14 h) in the present study, the DMA(III)-induced cell-cycle delay was still detectable.
In conclusion, the presented results reveal that the uptake capabilities of arsenic compounds are dependent upon both the cell type and the arsenic species: We noted a resistance to intracellular accumulation of arsenic, either due to increased resistance at the uptake level or an enhanced efflux mechanism by Hep G2 cells in comparison to CHO-9 cells. We have shown that the poorly membrane-permeable pentavalent organoarsenic compounds MMA(V), DMA(V), and TMAO(V) are able to induce DNA damage, but only under forced uptake conditions. The induced genotoxic effects were directly correlated to the increased intracellular arsenic concentrations. These data reveal that cellular resistance to MMA(V), DMA(V), and TMAO(V) occurs at the uptake and not intracellular level. We found that As i (V), MMA(III), MMA(V), DMA(V), and TMAO were present in the cytosol and not externally bound to cell membranes for either fibroblasts or heptaocytes. 
